Nu-Med Plus Introduces Portable/Rechargeable Nitric Oxide Delivery System

SALT LAKE CITY, UT--(Marketwired - March 31, 2015) -

Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device development company, announced it has completed the development of a lightweight Portable/Rechargeable Nitric Oxide Delivery System.

This Nitric Oxide System has the capability to deliver high purity NO in prescribed intervals or 24 hours per day at controlled doses by means of nasal cannula or face mask. Jeff Robins, President and CEO of Nu-Med Plus, Inc., remarked, “We are thrilled to introduce this mobile, rechargeable, lightweight unit which will be practical outside of hospital settings, benefiting underserved chronic therapies and aiding needed treatments in developing nations.”

About Nu-Med Plus, Inc.

Nu-Med Plus, Inc. is a medical device development company created to explore medical applications of newly developed technologies. The strategy is to focus on high growth potential markets where there is a clearly defined need recognized by the medical community that can be addressed by Nu-Med Plus and its technical expertise. Initial research and product development has been in the delivery of nitric oxide gas for therapeutic use. For more company information please visit www.nu-medplus.com.

Forward-Looking Statements
Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management’s current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. The Company cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond the Company’s control. Such factors include, among other things: risks and uncertainties relating to the Company’s ability to complete proposed private placement financing. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward looking information. Except as required under applicable securities legislation, the Company undertakes no obligation to publicly update or revise forward-looking information.